186 related articles for article (PubMed ID: 25582217)
1. Radiation therapy at the end of life: a population-based study examining palliative treatment intensity.
Kress MA; Jensen RE; Tsai HT; Lobo T; Satinsky A; Potosky AL
Radiat Oncol; 2015 Jan; 10():15. PubMed ID: 25582217
[TBL] [Abstract][Full Text] [Related]
2. Age disparity in palliative radiation therapy among patients with advanced cancer.
Wong J; Xu B; Yeung HN; Roeland EJ; Martinez ME; Le QT; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):224-30. PubMed ID: 25195994
[TBL] [Abstract][Full Text] [Related]
3. Utilization of palliative radiotherapy for bone metastases near end of life in a population-based cohort.
Tiwana MS; Barnes M; Kiraly A; Olson RA
BMC Palliat Care; 2016 Jan; 15():2. PubMed ID: 26748495
[TBL] [Abstract][Full Text] [Related]
4. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
Wang K; Sheets NC; Basak R; Chen RC
Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
[TBL] [Abstract][Full Text] [Related]
5. Trends in end-of-life care and health care spending in women with uterine cancer.
Margolis B; Chen L; Accordino MK; Clarke Hillyer G; Hou JY; Tergas AI; Burke WM; Neugut AI; Ananth CV; Hershman DL; Wright JD
Am J Obstet Gynecol; 2017 Oct; 217(4):434.e1-434.e10. PubMed ID: 28709581
[TBL] [Abstract][Full Text] [Related]
6. Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States.
Guadagnolo BA; Liao KP; Elting L; Giordano S; Buchholz TA; Shih YC
J Clin Oncol; 2013 Jan; 31(1):80-7. PubMed ID: 23169520
[TBL] [Abstract][Full Text] [Related]
7. Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer.
Fang P; Jagsi R; He W; Lei X; Campbell EG; Giordano SH; Smith GL
J Clin Oncol; 2019 Jul; 37(20):1721-1731. PubMed ID: 31141431
[TBL] [Abstract][Full Text] [Related]
8. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
9. Increasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States.
Guadagnolo BA; Liao KP; Giordano SH; Elting LS; Buchholz TA; Shih YC
J Oncol Pract; 2014 Jul; 10(4):e269-76. PubMed ID: 24756144
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care in palliative radiotherapy: a population-based study.
Murphy JD; Nelson LM; Chang DT; Mell LK; Le QT
J Oncol Pract; 2013 Sep; 9(5):e220-7. PubMed ID: 23943892
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer.
Robinson TJ; Dinan MA; Li Y; Lee WR; Reed SD
J Palliat Med; 2015 Nov; 18(11):933-9. PubMed ID: 26241733
[TBL] [Abstract][Full Text] [Related]
12. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer.
Hayman JA; Abrahamse PH; Lakhani I; Earle CC; Katz SJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1001-7. PubMed ID: 17689029
[TBL] [Abstract][Full Text] [Related]
13. Trends in the use of postprostatectomy therapies for patients with prostate cancer: a surveillance, epidemiology, and end results Medicare analysis.
Sheets NC; Hendrix LH; Allen IM; Chen RC
Cancer; 2013 Sep; 119(18):3295-301. PubMed ID: 23842985
[TBL] [Abstract][Full Text] [Related]
14. Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.
Dinan MA; Li Y; Zhang Y; Stewart SB; Curtis LH; George DJ; Reed SD
Clin Genitourin Cancer; 2016 Feb; 14(1):28-37.e2. PubMed ID: 26382223
[TBL] [Abstract][Full Text] [Related]
15. Patterns and Yearly Time Trends in the Use of Radiation Therapy During the Last 30 Days of Life Among Patients With Metastatic Rectal Cancer in the United States From 2004 to 2012.
Becerra AZ; Probst CP; Fleming FJ; Xu Z; Aquina CT; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Katz AW; Monson JR; Jusko TA
Am J Hosp Palliat Care; 2018 Feb; 35(2):336-342. PubMed ID: 28494653
[TBL] [Abstract][Full Text] [Related]
16. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ
Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer.
Quek RG; Master VA; Ward KC; Lin CC; Virgo KS; Portier KM; Lipscomb J
Cancer; 2013 Oct; 119(20):3619-28. PubMed ID: 23913478
[TBL] [Abstract][Full Text] [Related]
18. The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.
Feuer EJ; Rabin BA; Zou Z; Wang Z; Xiong X; Ellis JL; Steiner JF; Cynkin L; Nekhlyudov L; Bayliss E; Hankey BF
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):265-74. PubMed ID: 25417240
[TBL] [Abstract][Full Text] [Related]
19. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death.
Chen CT; Li L; Brooks G; Hassett M; Schrag D
Health Serv Res; 2018 Aug; 53(4):2118-2132. PubMed ID: 28748564
[TBL] [Abstract][Full Text] [Related]
20. Palliative radiation therapy in the last 30 days of life: A systematic review.
Park KR; Lee CG; Tseng YD; Liao JJ; Reddy S; Bruera E; Yennurajalingam S
Radiother Oncol; 2017 Nov; 125(2):193-199. PubMed ID: 29050955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
